Summary This article explores the groundbreaking research funded by Diabetes UK and the NIHR to combat diabetes distress, a pervasive issue among individuals with type 1 diabetes. The “D-Stress” program aims to revolutionize diabetes care […]
Summary Scientists have identified promising new pathways for reversing diabetic retinopathy, a leading cause of blindness. These breakthroughs offer hope for earlier intervention and improved vision outcomes for millions affected by this diabetes-related eye disease. […]
Summary This article explores groundbreaking research on HLA matching in islet transplantation for type 1 diabetes. It discusses the potential of matching donors and recipients to improve transplant outcomes and reduce the need for immunosuppressants. […]
Summary A groundbreaking stem cell transplant derived from a patient’s own cells has enabled a person with type 1 diabetes to produce insulin, potentially eliminating the need for immunosuppressants. This marks the first successful instance […]
Summary This article explores the increased prevalence of geriatric syndromes in older adults with diabetes, emphasizing the need for multidisciplinary care strategies. A recent meta-analysis revealed higher rates of cognitive impairment, depression, falls, functional impairment, […]
Summary A recent study suggests a potential link between certain diabetes medications and a lower risk of COPD flare-ups. SGLT-2 inhibitors, commonly used to treat type 2 diabetes, showed the most promising results in reducing […]
Summary A recent study suggests that drinking ketones may improve heart health in individuals with type 2 diabetes. Researchers found that participants with type 2 diabetes experienced improved cardiac efficiency after consuming a ketone ester […]
Summary A groundbreaking three-year study reveals that tirzepatide, a dual GIP and GLP-1 receptor agonist, significantly reduces the risk of developing type 2 diabetes by up to 94% in individuals with prediabetes and obesity. Participants […]
Summary Senseonics has achieved a significant milestone in diabetes management by submitting its Eversense 365 CGM system for CE Mark approval. This innovative system offers a groundbreaking year-long sensor duration, eliminating the need for frequent […]
Summary New research reveals that popular diabetes and obesity drugs, known as GLP-1 receptor agonists, may also protect against kidney disease. Studies show these drugs can reduce kidney deterioration and failure, regardless of diabetes status. […]
© 2025 Newsguru LTD. All rights reserved.